Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies

Contributed by: Business Wire

Logo

Tags

Health

Other Health

Clinical Trials

General Health

Pharmaceutical

Biotechnology

Galderma Begins Trading in the Swiss Market Index

More Like This

Galderma Announces Intention to Float on the SIX Swiss Exchange

Galderma Launches IPO on the SIX Swiss Exchange and Sets Price Range

Galderma Prices IPO at CHF 53 Per Share and Will Start Trading on the SIX Swiss Exchange Tomorrow

Galderma Welcomes Increased Equity Investment From L’Oréal

Galderma Delivers a Strong Start to the Year With Record Net Sales of Over 1 Billion USD for the First Quarter and 12.4% Year-on-Year Growth

Galderma to pursue a new scientific partnership with L’Oréal to further advance its category leadership in dermatology

Galderma Successfully Issued an Inaugural CHF 500 Million Bond

Galderma Reports Strong Start to the Year, Delivering First Quarter 2026 Net Sales of 1.473 Billion USD, Growing 25.5% at Constant Currency